Luke Lee (venture capitalist)
Luke Lee (venture capitalist)
Luke J. Lee is a cancer biologist, entrepreneur, and venture capitalist. He is the co-founder and CEO of 3T Biosciences. [undefined]
Early Life & Education
Lee graduated from Johns Hopkins University in 2011 with a Bachelor's degree in Cellular & Molecular Biology. In 2017, he earned his Ph.D. in Cancer Biology at the Stanford University School of Medicine. [undefined]
While at Stanford, he was the Co-President of the Stanford Biotechnology Group.
Career
Asset Management Ventures
In June 2013, while he was a Ph.D. candidate at Stanford University, he was a Principal at a VC called Asset Management Ventures. While there, he gained experience with over 20 investments from company formation to exit, including the company he co-founded. [undefined] [6]
3T Biosciences
In 2017, Luke Lee joined the 3T Biosciences team as a co-founder and the CEO.
3T Biosciences uses machine learning to predict what chemicals would be on cancer cells but not normal ones. In addition, it uses a new genetic engineering process to modify T cells (a type of white blood cell), to target those chemicals. [undefined]
As of November 2017, the company has raised over $12 million.
[undefined] Some investors include Lee's previous company, Asset Management Ventures, Facebook's founding president Sean Parker, Peter Thiel, and Charles River Ventures. [undefined]
Awards & Accomplishments
In November 2017, Luke Lee and his co-founders Marvin Gee and Leah Sibener made the Forbes 30 Under 30 list for 2018; they are listed in the 'Healthcare' sub-list. [undefined]
Personal Life
In his spare time, Luke enjoys listening to the San Francisco Symphony, as well as playing soccer and golf. He also like to make macarons. [undefined]